Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Trulieve Cannabis Corp. (TRUL) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 8-K Quarterly results
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Investor presentation, Quarterly results
Docs: "FORM 8-K",
"Trulieve Reports Second Quarter 2023 Results Highlighting Progress on 2023 Plan",
"Corporate Presentation"
07/21/2023 8-K Quarterly results
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 8-K Investor presentation, Quarterly results
Docs: "FORM 8-K",
"Trulieve Reports First Quarter 2023 Results Marking Progress on Cash Objectives",
"Corporate Presentation"
05/01/2023 8-K Quarterly results
05/01/2023 ARS Form ARS - Annual Report to Security Holders:
05/01/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/01/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/05/2023 8-K Other Events  Interactive Data
Docs: "FORM 8-K"
04/05/2023 10-K/A Annual Report for the period ended December 31, 2021 [amend]
03/08/2023 10-K Annual Report for the period ended December 31, 2022
03/08/2023 8-K Investor presentation, Quarterly results
Docs: "FORM 8-K",
"Trulieve Reports Fourth Quarter and Record Full Year 2022 Results Exceeding $1.2 Billion in Revenue",
"Corporate Presentation"
02/24/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
01/25/2023 SC 13G/A Cowen Financial Products LLC reports a 7% stake in Trulieve Cannabis Corp.
12/21/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "FORM 8-K",
"Trulieve Announces Closing of $71.5 Million Financing TALLAHASSEE, Fla. - December 21, 2022 - Trulieve Cannabis Corp. , a leading and top-performing cannabis company in the U.S., today announced the closing of a commercial loan secured by a cultivation and manufacturing site in Florida for aggregate gross proceeds of $71.5 million. Trulieve will pay interest at a fixed rate of 7.53% for the duration of the five-year loan. Lenders were comprised of three banks, with Valley National Bank serving as lead agent. The Company intends to use the net loan proceeds for general corporate purposes. “We are pleased to announce this non-dilutive financing at industry leading terms, particularly given the current macroeconomic backdrop,” said Trulieve Chief Executive Officer, Kim Rivers. “This loan pro..."
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/09/2022 8-K Investor presentation, Quarterly results
Docs: "FORM 8-K",
"Trulieve Reports Third Quarter 2022 Results and Drives Forward Progress on Strategic Vision",
"Corporate Presentation"
08/10/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/10/2022 8-K Quarterly results
07/12/2022 EFFECT Form EFFECT - Notice of Effectiveness:
07/12/2022 EFFECT Form EFFECT - Notice of Effectiveness:
07/08/2022 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
07/08/2022 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
07/07/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
07/07/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
06/10/2022 8-K Quarterly results
05/24/2022 8-K/A Quarterly results
05/12/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/12/2022 8-K Quarterly results
04/28/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/05/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "FORM 8-K"
03/30/2022 10-K Annual Report for the period ended December 31, 2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy